Thermo Fisher Scientific | TMO - Operating Profit

Stock Price
503.46
Daily Change
13.96 2.85%
Monthly
-1.28%
Yearly
11.00%
Q2 Forecast
476.67

Thermo Fisher Scientific reported $2.3B in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Abbott USD 2.25B 73M Dec/2025
Agilent USD 353M 90M Dec/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Bio Techne USD 54.46M 6.8M Dec/2025
Bio-Rad Laboratories USD 63.9M 13.2M Sep/2025
Boston Scientific USD 1.24B 203M Dec/2025
Bruker USD 76.3M 7.6M Dec/2025
Charles River Laboratories USD 75.82M 57.98M Dec/2025
Danaher USD 1.5B 348M Dec/2025
Dentsply International USD 538M 26M Dec/2025
Edwards Lifesciences USD 370.3M 54.8M Dec/2025
General Electric Aerospace USD 1.77B 536M Dec/2025
Henry Schein USD 186M 12M Dec/2025
Hologic USD 237M 16M Dec/2025
Illumina USD 256M 6M Dec/2025
Intuitive Surgical USD 865.3M 97.5M Dec/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Laboratory Of America USD 382M 15.3M Dec/2025
Medtronic USD 1.74B 40M Dec/2025
Mettler Toledo International USD 351.93M 57.73M Dec/2025
Myriad Genetics USD -3M 20.3M Dec/2025
Olympus JPY 28B 5.56B Dec/2025
OraSure Technologies USD -13.59M 2.13M Dec/2025
Quest Diagnostics USD 386M 0 Dec/2025
Repligen USD 19.97M 7.29M Dec/2025
Revvity USD 145.83M 47.49M Dec/2025
Stryker USD 1.97B 609M Dec/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
Veracyte USD 24.63M 1.52M Dec/2025
Waters USD 270.52M 78.4M Dec/2025
Zimmer Biomet Holdings USD 302.9M 35.4M Dec/2025